医療用ガスおよび機器の世界市場予測（～2023年）...市場調査レポートについてご紹介

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 LIMITATIONS
1.5 CURRENCY
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MEDICAL GASES & EQUIPMENT MARKET OVERVIEW
4.2 ASIA PACIFIC: MEDICAL GASES & EQUIPMENT MARKET, BY EQUIPMENT TYPE AND COUNTRY, 2018
4.3 GEOGRAPHIC SNAPSHOT OF THE MEDICAL GASES & EQUIPMENT MARKET
4.4 GEOGRAPHIC MIX: MEDICAL GASES & EQUIPMENT MARKET
4.5 MEDICAL GASES & EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Increasing incidence of respiratory diseases as a result of the high prevalence of tobacco use and rising pollution levels
5.2.2 RISING INCIDENCE OF PRETERM BIRTHS
5.2.2.1 Growing demand for home healthcare
5.2.3 MARKET RESTRAINTS
5.2.3.1 Declining federal reimbursements for respiratory diagnostics and therapies
5.2.3.2 Global helium shortage
5.2.4 MARKET OPPORTUNITIES
5.2.4.1 Market expansion in emerging countries across APAC
5.2.4.2 Technological advancements
5.2.5 MARKET CHALLENGES
5.2.5.1 Changes in medical gas calibration standards
5.2.5.2 Lack of awareness and large untreated population
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 FOCUS ON EQUIPMENT INTEGRATION AND CONVENIENCE
6.2.2 INCLINATION TOWARDS MODERN BULK GAS SUPPLY CHAINS— MICROBULK AND SMALL BULK
6.2.3 CONSOLIDATION
6.3 REGULATORY ANALYSIS
6.3.1 NORTH AMERICA
6.3.1.1 US
6.3.1.2 Canada
6.3.2 EUROPE
6.3.3 ASIA PACIFIC
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
6.4 PRODUCT PORTFOLIO ANALYSIS
7 MEDICAL GASES AND EQUIPMENT MARKET, BY TYPE
7.1 INTRODUCTION
7.2 MEDICAL GASES
7.2.1 PURE MEDICAL GASES
7.2.2 PURE MEDICAL GASES MARKET, BY TYPE
7.2.2.1 Oxygen
7.2.2.1.1 Hospitals
7.2.2.1.1.1 Improving healthcare infrastructure to drive the demand for oxygen gas in hospitals
7.2.2.1.2 Home care settings
7.2.2.1.2.1 Rising healthcare costs and rapid growth in the aging population globally led to the emergence of the home care settings market
7.2.2.2 Carbon dioxide
7.2.2.2.1 Rise in surgeries performed augments the demand for medical-grade CO2
7.2.2.3 Nitrogen
7.2.2.3.1 Growing number of cryopreservation and biopreservation procedures to drive the nitrogen market
7.2.2.4 Nitrous oxide
7.2.2.4.1 Growing number of preterm births to drive the nitrous oxide market
7.2.2.5 Medical air
7.2.2.5.1 Growing use of medical air as an alternative to anesthetic gases to drive the growth of this market
7.2.2.6 Helium
7.2.2.6.1 Shortage of helium could slow the growth of this market
7.2.3 PURE MEDICAL GASES MARKET, BY FORM OF DELIVERY
7.2.3.1 High-pressure cylinders
7.2.3.1.1 Growing preference for home treatment among patients to propel the growth of this segment
7.2.3.2 Liquid tanks
7.2.3.2.1 Rising use of oxygen, carbon dioxide, and nitrogen in various clinical applications to drive the adoption of liquid tanks
7.2.3.3 Bulk delivery
7.2.3.3.1 Growing need of an uninterrupted supply of gas to drive the adoption of bulk delivery
7.2.4 MEDICAL GAS MIXTURES
7.2.4.1 Blood-gas mixtures
7.2.4.1.1 Blood-gas mixtures to account for the largest market share in 2018
7.2.4.2 Lung diffusion mixtures
7.2.4.2.1 Rising prevalence of respiratory, gastrointestinal, and cardiovascular disorders to drive the demand for lung diffusion mixtures
7.2.4.3 Nitrous oxide-oxygen mixtures
7.2.4.3.1 Growing prevalence of cardiovascular diseases driving the demand for carbon dioxide-oxygen mixtures
7.2.4.4 Carbon dioxide-oxygen mixtures
7.2.4.4.1 Various applications from dental procedures to obstetric procedures drive the demand for nitrous oxide-oxygen mixtures
7.2.4.5 Laser-gas mixtures
7.2.4.5.1 Wide applications of laser-gas mixtures in skin and ophthalmic surgeries to propel the growth of this market
7.2.4.6 Aerobic gas mixtures
7.2.4.6.1 Aerobic gas mixtures are essential for controlling the atmosphere of cell cultures, a key factor driving demand growth
7.2.4.7 Anaerobic gas mixtures
7.2.4.7.1 Rising demand from laboratories for the incubation of microorganisms to drive the growth of this segment
7.2.4.8 Ethylene oxide/sterilant gas mixtures
7.2.4.8.1 Wide usage of ethylene oxide as a sterilizing agent to drive the growth of this segment
7.2.4.9 Helium-oxygen mixtures
7.2.4.9.1 High costs restrain the widespread use of heliox in medical applications
7.3 MEDICAL GAS EQUIPMENT
7.3.1 EQUIPMENT ACCESSORIES
7.3.1.1 Vacuum systems
7.3.1.1.1 Vacuum systems to account for the largest share in 2018
7.3.1.2 Manifolds
7.3.1.2.1 Significantly increased workplace safety and reduced accidents involving contamination to drive the adoption of manifolds
7.3.1.3 Regulators
7.3.1.3.1 New product launches to drive the adoption of regulators
7.3.1.4 Flowmeters
7.3.1.4.1 Increasing efforts to calculate smaller proportions of gases to ensure patient safety are driving the adoption of flowmeters
7.3.1.5 Suction regulators
7.3.1.5.1 Rising use in healthcare facilities for surgeries and other medical applications to propel market growth
7.3.1.6 Hoses
7.3.1.6.1 Significant use in a number of medical applications to drive the growth of this segment
7.3.1.7 Valves with integrated pressure regulators (VIPRs)
7.3.1.7.1 Technological advancements to drive the adoption of valves with integrated pressure regulators
7.3.1.8 Outlets
7.3.1.8.1 Outlets to register the highest growth between 2018 and 2023
7.3.1.9 Monitoring systems (alarms & monitors)
7.3.1.9.1 Recent advances in gas monitoring systems to drive adoption during the forecast period
7.3.1.10 Medical air compressors
7.3.1.10.1 Growing use of energy-efficient and cost-effective products to propel market growth
7.3.2 GAS DELIVERY SYSTEMS
7.3.2.1 Cost-effective and safe alternatives to gas cylinders in hospitals and laboratory environments to drive market growth
7.3.3 CRYOGENIC PRODUCTS (FREEZERS)
7.3.3.1 Growing use in various application to drive the adoption of cryogenic products
8 MEDICAL GASES AND EQUIPMENT MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 THERAPEUTIC APPLICATIONS
8.2.1 RESPIRATORY THERAPIES
8.2.1.1 Prevalence of asthma and allergic diseases has increased over the years
8.2.2 CARDIOVASCULAR THERAPIES
8.2.2.1 Market growth will be driven by the growing disease incidence and importance of medical gases in their treatment
8.2.3 ANESTHESIA DELIVERY
8.2.3.1 Nitrous oxide, among others, is often used as an inhalation anesthetic
8.2.4 CRYOSURGERY
8.2.4.1 Painlessness of cryosurgical procedures driving their adoption
8.2.5 OTHER THERAPEUTIC APPLICATIONS
8.2.5.1 Rising incidence of neurological disorders and traumatic brain injuries to increase the demand for medical gases
8.3 PHARMACEUTICAL MANUFACTURING & RESEARCH
8.3.1 DRUG DISCOVERY
8.3.1.1 Growing use of gases and gas mixtures, increasing investments in R&D will contribute to the growth of this application segment
8.3.2 PHARMACEUTICAL MANUFACTURING
8.3.2.1 Regulatory concerns have driven the demand for pure medical gases for pharmaceutical manufacturing
8.3.3 PROCESS DEVELOPMENT
8.3.3.1 Growing use of process development technologies will support market growth
8.3.4 QUALITY CONTROL
8.3.4.1 Ensuring purity of specialty and medical gases is crucial
8.4 DIAGNOSTIC APPLICATIONS
8.4.1 MEDICAL IMAGING
8.4.1.1 Companies are focusing on bundling product & service offerings for diagnostic imaging
8.4.2 GENERAL LABORATORY APPLICATIONS
8.4.2.1 Growing focus on cryobiology and cell-based research will support segmental growth
8.5 OTHER APPLICATIONS
9 MEDICAL GASES AND EQUIPMENT MARKET, BY END USER
9.1 INTRODUCTION
9.1.1 HOSPITALS
9.1.1.1 Hospitals are the major end users of medical gases and equipment
9.1.2 HOME HEALTHCARE
9.1.2.1 Home healthcare segment to witness the highest growth during the forecast period, primarily due to the rising global prevalence of chronic diseases
9.1.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.1.3.1 Pharmaceutical & biotechnology companies use medical gases to process active substances, medicaments, and medicinal products
9.1.4 ACADEMIC & RESEARCH INSTITUTIONS
9.1.4.1 Growing number of companies are increasingly opting to outsource their research functions to academic and research institutes
9.1.5 EMERGENCY SERVICES
9.1.5.1 Emergency services mainly rely on oxygen and nitronox
10 MEDICAL GASES AND EQUIPMENT MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 US has the highest healthcare expenditure among OECD countries
10.2.2 CANADA
10.2.2.1 Changes in demographics and care patterns have favored the growth of the Canadian home care market
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Approximately 85% of the German population has insurance coverage
10.3.2 UK
10.3.2.1 MHRA regulates medical gas equipment in the country
10.3.3 FRANCE
10.3.3.1 Well-established French healthcare system is ranked among the world’s best
10.3.4 ITALY
10.3.4.1 Rapid growth in geriatric population and rising life expectancy have driven the demand for healthcare
10.3.5 SPAIN
10.3.5.1 Government debt, shortcomings of Spain’s medical devices sector will negatively affect the market
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.1.1 Mandatory enrolment in healthcare insurance program ensures widespread access to quality care
10.4.2 CHINA
10.4.2.1 Lifestyle changes and growing air pollution levels have contributed to disease incidence in China
10.4.3 INDIA
10.4.3.1 Acute respiratory disease is a major concern in India
10.4.4 AUSTRALIA
10.4.4.1 Rising disease prevalence, geriatric population, and infrastructural development will ensure steady market growth
10.4.5 SOUTH KOREA
10.4.5.1 The country is gaining prominence as a medical tourism hub
10.4.6 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 BRAZIL
10.5.1.1 Only half of Brazil’s population can access universal healthcare
10.5.2 ARGENTINA
10.5.2.1 Long waiting times and varying quality of healthcare services in public hospitals may hinder market prospects
10.5.3 MEXICO
10.5.3.1 Mexico is the second-most-popular medical tourism hub for US patients
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST AND AFRICA
10.6.1 MARKET TO RECEIVE A BOOST DUE TO ONGOING INFRASTRUCTURAL DEVELOPMENT ACTIVITY
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 NEW PRODUCT LAUNCHES
11.3.2 EXPANSIONS
11.3.3 AGREEMENTS, PARTNERSHIPS, AND JOINT VENTURES
11.3.4 OTHERS
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 AIR LIQUIDE
12.2 THE LINDE GROUP
12.3 AIR PRODUCTS AND CHEMICALS, INC.
12.4 PRAXAIR, INC.
12.5 TAIYO NIPPON SANSO CORPORATION (MATHESON TRI-GAS INC.)
12.6 ATLAS COPCO AB
12.7 GCE HOLDING AB
12.8 MESSER GROUP GMBH
12.9 SOL SPA
12.1 ROTAREX S.A.
12.11 ADDITIONAL COMPANY PROFILES
12.11.1 MEDICAL GAS SOLUTIONS LIMITED
12.11.1.1 Business Overview
12.11.1.2 Products offered
12.11.2 SCI ANALYTICAL
12.11.2.1 Business Overview
12.11.2.2 Products offered
12.11.3 AMICO CORPORATION
12.11.3.1 Business Overview
12.11.3.2 Products offered
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS